TSC22D3 and neoplasm: One recent study demonstrates in vivo and in vitro that, as a result of tumor/microenvironment interaction, GILZ is highly upregulated in tumor microenvironment DCs, resulting in the suppression of immune T-cell response against cancer, which can be restored via GILZ blockade120.